NEULASTIM Trademark

Trademark Overview

On Tuesday, September 27, 2005, a trademark application was filed for NEULASTIM with the United States Patent and Trademark Office. The USPTO has given the NEULASTIM trademark a serial number of 78721734. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 10, 2010. This trademark is owned by Amgen Inc.. The NEULASTIM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, pharmaceuticals for use in stimulating white blood cell production
neulastim

General Information

Serial Number78721734
Word MarkNEULASTIM
Filing DateTuesday, September 27, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 10, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, pharmaceuticals for use in stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, May 10, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 10, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 29, 2009EXTENSION 5 GRANTED
Thursday, September 24, 2009EXTENSION 5 FILED
Thursday, September 24, 2009TEAS EXTENSION RECEIVED
Wednesday, March 25, 2009EXTENSION 4 GRANTED
Tuesday, March 24, 2009EXTENSION 4 FILED
Tuesday, March 24, 2009TEAS EXTENSION RECEIVED
Thursday, September 11, 2008EXTENSION 3 GRANTED
Friday, September 5, 2008EXTENSION 3 FILED
Thursday, September 11, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 5, 2008TEAS EXTENSION RECEIVED
Thursday, April 17, 2008EXTENSION 2 GRANTED
Monday, March 31, 2008EXTENSION 2 FILED
Monday, March 31, 2008TEAS EXTENSION RECEIVED
Wednesday, October 3, 2007EXTENSION 1 GRANTED
Monday, September 24, 2007EXTENSION 1 FILED
Monday, September 24, 2007TEAS EXTENSION RECEIVED
Friday, June 29, 2007ASSIGNED TO LIE
Tuesday, April 10, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 16, 2007PUBLISHED FOR OPPOSITION
Wednesday, December 27, 2006NOTICE OF PUBLICATION
Wednesday, November 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 29, 2006ASSIGNED TO LIE
Friday, November 10, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 24, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2006NON-FINAL ACTION E-MAILED
Friday, March 31, 2006NON-FINAL ACTION WRITTEN
Thursday, March 30, 2006ASSIGNED TO EXAMINER
Monday, October 3, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

neulastim blood cell production white stimulating preparations namely pharmaceuticals pharmaceutical